Shahera Safrin

Shahera Safrin is a legal practitioner in Singapore. With documented cases from 2023 to 2024. The lawyer has handled 3 cases in Singapore's courts. Associated with 2 law firms. The lawyer demonstrates particular expertise in undue influence and winding up. Their track record shows a 67.0% success rate in resolved cases. They have managed 2 complex cases, representing 67% of their total caseload.

Areas of Practice and Expertise

Shahera Safrin has demonstrated expertise across 20 primary practice areas, with significant experience in commercial disputes and undue influence.

Practice AreaCase Volume
Commercial Disputes2 cases
Undue Influence2 cases
Contract Law2 cases
Winding Up2 cases
Minority Oppression2 cases
Contractual terms1 cases
Abuse of Process1 cases
Costs1 cases
Duress1 cases
Estoppel1 cases
Remedies1 cases
Civil Procedure1 cases
Lifting corporate veil1 cases
Company Law1 cases
Bankruptcy1 cases
Pharmaceutical Process Chemistry1 cases
Civil Litigation1 cases
Corporate Law1 cases
Intellectual Property Law1 cases
Patents1 cases

Law Firm Affiliations

Shahera Safrin has been affiliated with 2 law firms. The most active affiliation involves 2 cases.

Case Complexity Analysis

Analysis of Shahera Safrin's case complexity based on the number of parties involved and case characteristics.

Complexity Overview

Average Parties per Case
5.3
Complex Cases
2 (67%)
Cases with more than 3 parties

Complexity by Case Type

TypeCases
Lost13.0 parties avg
Won26.0 parties avg

Complexity Trends Over Time

YearCases
202313.0 parties avg
202426.0 parties avg

Case Outcome Analytics

Analysis of Shahera Safrin's case outcomes, including distribution by type, yearly trends, and monetary outcomes where applicable.

Outcome Distribution

Outcome TypeCases
Lost1(33%)
Won2(67%)

Monetary Outcomes

CurrencyAverage
SGD448,500.002 cases

Yearly Outcome Trends

YearTotal Cases
20231
1
20242
2

Case History

Displaying all 3 cases

Case
02 Jul 2024
Tay Yiming (Claimant)Won
18 Jan 2024
Tay Yiming (Claimant)Won
28 Dec 2023
Johnson & Johnson Pte Ltd (Plaintiff)Lost